Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.
Kao-Ping ChuaRena M ContiPooja LagisettyAmy S B BohnertUsha NuliyaluThuy D NguyenPublished in: Journal of general internal medicine (2024)
Among commercially insured and Medicare patients, buprenorphine prescription abandonment is rare and only minimally associated with cost-sharing. Findings suggest elimination of buprenorphine cost-sharing should only be one component of a larger, multi-faceted campaign to increase buprenorphine dispensing.